Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.38 is 84% below its 5-year average of 8.42, near the low end of its 5-year range (1.38–16.76).
As of the fiscal period ended Tuesday, June 30, 2026. 45.98% below its 12-month average of 2.56.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.38.
QUICK RATIO (ACID-TEST)
1.38
QUICK RATIO (ACID-TEST) AVG TTM
2.56
QUICK RATIO (ACID-TEST) AVG 3Y
5.30
QUICK RATIO (ACID-TEST) AVG 5Y
8.42
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-45.98%
CURRENT VS 3Y AVG
-73.94%
CURRENT VS 5Y AVG
-83.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 794 covered companies
CURRENT VS SECTOR MEDIAN
-57.89%
vs the sector median at left
GoodRx Holdings, Inc.
Market Cap
$1.14B
Quick Ratio (Acid-Test)
1.38
TTM Avg
2.56
3Y Avg
5.30
5Y Avg
8.42
Market Cap
$1.15B
Quick Ratio (Acid-Test)
10.42
TTM Avg
4.62
3Y Avg
5.77
5Y Avg
6.99
Market Cap
$1.13B
Quick Ratio (Acid-Test)
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
Market Cap
$1.13B
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.54
3Y Avg
2.42
5Y Avg
2.25
Market Cap
$1.13B
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.01
3Y Avg
3.15
5Y Avg
3.64
Market Cap
$1.12B
Quick Ratio (Acid-Test)
2.93
TTM Avg
3.33
3Y Avg
2.34
5Y Avg
2.11
Market Cap
$1.17B
Quick Ratio (Acid-Test)
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
Market Cap
$1.11B
Quick Ratio (Acid-Test)
4.03
TTM Avg
3.74
3Y Avg
4.48
5Y Avg
4.84
Market Cap
$1.10B
Quick Ratio (Acid-Test)
5.23
TTM Avg
6.37
3Y Avg
10.25
5Y Avg
15.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.14B | 1.38 | 2.56 | 5.30 | 8.42 |
| Nektar Therapeutics (NKTR)vs › | $1.15B | 10.42 | 4.62 | 5.77 | 6.99 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 33.10 | 10.19 | 10.19 | 10.19 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 1.71 | 2.54 | 2.42 | 2.25 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 2.08 | 2.01 | 3.15 | 3.64 |
| OPKO Health, Inc. (OPK)vs › | $1.12B | 2.93 | 3.33 | 2.34 | 2.11 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 19.73 | 13.53 | 9.78 | 15.63 |
| STAAR Surgical Company (STAA)vs › | $1.11B | 4.03 | 3.74 | 4.48 | 4.84 |
| Replimune Group, Inc. (REPL)vs › | $1.10B | 5.23 | 6.37 | 10.25 | 15.62 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 11.59 | 21.25 | 14.51 | 14.51 |
Quick Ratio
1.38
Excludes inventory
Current Ratio
1.38
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.38 |
| 2026-03-31 | 1.47 |
| 2025-12-31 | 2.61 |
| 2025-09-30 | 3.11 |
| 2025-06-30 | 4.21 |
| 2025-03-31 | 5.23 |
| 2024-12-31 | 5.32 |
| 2024-09-30 | 5.48 |
| 2024-06-30 | 7.32 |
| 2024-03-31 | 6.29 |
| 2023-12-31 | 7.12 |
| 2023-09-30 | 8.23 |
| 2023-06-30 | 11.14 |
| 2023-03-31 | 13.15 |
| 2022-12-31 | 12.05 |
| 2022-09-30 | 10.34 |
| 2022-06-30 | 11.23 |
| 2022-03-31 | 16.76 |
| 2021-12-31 | 13.42 |
| 2021-09-30 | 14.47 |
| 2021-06-30 | 16.43 |
| 2021-03-31 | 17.82 |
| 2020-12-31 | 18.24 |
| 2020-09-30 | 19.63 |
| 2020-06-30 | 3.34 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.59 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
